Position in NRXS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$2,960,000
+$1,144,001 QoQ
Shares Held
400,000
0.0% QoQ
Ownership
3.23%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 74%
Shared 26%
None 0%
Common Shares in NRXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AIGH Capital Management LLC holds $126,310,878 across 15 Biotechnology names. NRXS ranks #12 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VNDA |
Vanda Pharmaceuticals Inc.
|
2,750,000 | $19,002,499 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
|
2,000,000 | $17,259,999 | |
| 3 | ABEO |
Abeona Therapeutics Inc.
|
3,100,000 | $13,888,000 | |
| 4 | LRMR |
Larimar Therapeutics, Inc.
|
3,000,000 | $13,499,999 | |
| 5 | FENC |
Fennec Pharmaceuticals Inc.
|
1,981,501 | $12,186,230 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
1,200,000 | $11,183,999 | |
| 7 | VSTM |
Verastem, Inc.
|
2,000,000 | $10,599,999 | |
| 8 | TARA |
Protara Therapeutics, Inc.
|
1,622,733 | $8,454,438 |
All Filings in NRXS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,960,000 | 400,000 | Shares | Other | 2026-04-30 | |
| 2025-12-31 | $1,815,999 | 400,000 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $1,231,999 | 400,000 | Shares | Other | 2025-10-31 | |
| 2025-06-30 | $967,999 | 400,000 | Shares | Other | 2025-07-29 | |
| 2025-03-31 | $42,718 | 19,869 | Shares | Sole | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||